YEAR
- 2015.01.03 Structure-based design and synthesis of a bivalent iminobiotin analog showing strong affinity toward a low immunogenic streptavidin mutant. Kawato T, Mizohata E, Shimizu Y, Meshizuka T, Yamamoto T, Takasu N, Matsuoka M, Matsumura H, Kodama T, Kanai M, Doi H, Inoue T, Sugiyama A.Biosci. Biotechnol. Biochem. 2015;79(4):640-2. doi: 10.1080/09168451.2014.991692
- 2015.01.13 Structural features of interfacial tyrosine residue in ROBO1 fibronectin domain-antibody complex: Crystallographic, thermodynamic, and molecular dynamic analyses. Nakayama T, Mizohata E, Yamashita T, Nagatoishi S, Nakakido M, Iwanari H, Mochizuki Y, Kado Y, Yokota Y, Satoh R, Tsumoto K, Fujitani H, Kodama T, Hamakubo T, Inoue T.Protein Sci. 2015 Mar;24(3):328-40. doi: 10.1002/pro.2619
- 2015.02.02 Structure-based design of a streptavidin mutant specific for an artificial biotin analogue. Kawato T, Mizohata E, Shimizu Y, Meshizuka T, Yamamoto T, Takasu N, Matsuoka M, Matsumura H, Kodama T, Kanai M, Doi H, Inoue T, Sugiyama A.J. Biochem. 2015 Jun;157(6):467-75. doi: 10.1093/jb/mvv004
- 2015.02.05 A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells. Nishii Y, Yamaguchi M, Kimura Y, Hasegawa T, Aburatani H, Uchida H, Hirata K, Sakuma Y.Int. J. Oncol. 2015 Apr;46(4):1781-7. doi: 10.3892/ijo.2015.2880
- 2015.02.10 RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer. Takayama K, Suzuki T, Tsutsumi S, Fujimura T, Urano T, Takahashi S, Homma Y, Aburatani H, Inoue S.Oncotarget. 2015 Feb 10;6(4):2263-76. doi: 10.18632/oncotarget.2949
- 2015.02.21 Molecular dynamics simulation-based evaluation of the binding free energies of computationally designed drug candidates: importance of the dynamical effects. Yamashita T, Ueda A, Mitsui T, Tomonaga A, Matsumoto S, Kodama T, Fujitani H.Chem. Pharm. Bull. 2014;62(7):661-7. doi: 10.1248/cpb.c14-00132
- 2015.02.25 The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma. Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T.BMC Cancer. 2015 Feb 25;15:82. doi: 10.1186/s12885-015-1065-8
- 2015.03.05 Design and synthesis of biotin analogues reversibly binding with streptavidin. Yamamoto T, Aoki K, Sugiyama A, Doi H, Kodama T, Shimizu Y, Kanai M.Chem Asian J. 2015 Apr;10(4):1071-8. doi: 10.1002/asia.201500120
CLOSE